6988:TSENitto Denko Corp. Analysis
Data as of 2026-06-25 - not real-time
NT$13.60
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
WELLYSUN is trading at TWD 13.6, well below its 20‑day (TWD 14.44), 50‑day (TWD 14.86) and 200‑day (TWD 15.55) simple moving averages, signaling a sustained bearish price bias. The RSI of 30.9 hints at near‑oversold conditions, yet the MACD histogram remains negative and the overall trend is classified as bearish, with volume slipping and volatility running high at roughly 38.8%. The stock sits just above its identified support of TWD 13.35 and faces a distant resistance near TWD 17.75, while the DCF‑derived fair value of TWD 41.06 suggests a large valuation gap. Despite a respectable dividend yield of 3.31% and a low beta of 0.15, the company’s fundamentals are weak: revenue fell 24.6%, operating and profit margins are negative, and trailing EPS is –1.13. Cash on hand (TWD 330 M) exceeds debt (TWD 258 M), leaving a net‑cash position, but the high debt‑to‑equity ratio of 36% and negative ROE raise concerns about long‑term earnings sustainability. In this context, the dividend appears tenuous, as payouts are not backed by positive earnings. Overall, the technical picture offers a marginal chance of a short‑term bounce, but the fundamental backdrop remains challenging.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering just above technical support
- RSI near oversold but MACD still bearish
- Decreasing volume indicating weakening buying pressure
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Continued revenue decline and negative margins
- Lack of earnings recovery despite net cash position
- Large gap between market price and DCF fair value may reflect underlying risk
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Potential asset‑backed upside given low price-to-book
- Sustained dividend yield if cash flow remains positive
- Low market beta but high operational and earnings volatility
Key Metrics & Analysis
Financial Health
Revenue Growth-24.60%
Profit Margin-8.30%
ROE-8.01%
ROA-2.62%
Debt/Equity36.15
P/B Ratio0.9
Op. Cash FlowNT$114.8M
Free Cash FlowNT$134.6M
Industry P/E36.8
Technical Analysis
TrendBearish
RSI30.9
SupportNT$13.35
ResistanceNT$17.75
MA 20NT$14.44
MA 50NT$14.86
MA 200NT$15.55
MACDBearish
VolumeDecreasing
Fear & Greed Index87.7
Valuation
Fair ValueNT$41.06
GradeUndervalued
TypeValue
Dividend Yield3.31%
Risk Assessment
Beta0.15
Volatility38.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.